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.2012.07.Abstract Introduction: In spite of introduction of intermediate-acting neuromuscular blocking
drugs (NMBDs), incidence of postoperative residual muscle weakness is still high. The aim of this
trial is to study the effect of systemic lidocaine infusion on intraoperative consumption of rocuro-
nium and TOF ratios at extubation and on arrival to postanesthesia care unit (PACU).
Methods: Forty-six ASA I–III patients aged 16–60 yr were randomly allocated into two groups:
lidocaine (L) group (n= 23) and control (C) group (n= 23). After induction of standard endotra-
cheal general anesthesia with fentanyl, propofol and rocuronium, patients of group L were given i.v.
lidocaine bolus (1.5 mg kg1) followed by continuous infusion (1.5 mg kg1 h1) till time of endo-
tracheal extubation while patients in group C were given equal volumes of normal saline. Rocuro-
nium was titrated based on clinical signs. On conclusion of surgery, neostigmine was given to
reverse the effects of rocuronium if TOF count was two or more. Immediately before extubation,
TOF ratio was measured and recorded and considered the primary outcome.
Results: There were no signiﬁcant differences between the two study groups regarding intraopera-
tive fentanyl doses or core temperature at the end of surgery. End-tidal sevoﬂurane concentrations
were signiﬁcantly lower in group L than in group P (P< 0.01). The dose of rocuronium was signif-
icantly less in group L than in group C (P= 0.001). Train-of four ratios were signiﬁcantly higher in
group L than in group C either before extubation (P< 0.001) or on arrival to PACU (P= 0.001).
Conclusion: The current study shows that intraoperative use of i.v. lidocaine infusion in generally
anesthetized patients can result in higher TOF ratios at time of extubation and on arrival to PACU
when rocuronium was given based on clinical signs.
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282 A.M. Omar1. Introduction
In spite of introduction of intermediate-acting neuromuscular
blocking drugs (NMBDs), incidence of postoperative residual
muscle weakness is still high [1–6]. There is evidence that qual-
itative monitoring of neuromuscular function does not affect
the postoperative train-of-four (TOF) ratios in comparison
to relying on clinical signs per se [7]. Surveys of clinical practice
in Europe and USA suggest that NMBDs are often adminis-
tered without proper monitoring [8,9]. Systemic lidocaine infu-
sion has been used effectively to decrease the requirements of
analgesics perioperatively [10–12].
However, the effect of systemic lidocaine infusion on intra-
operative consumption of NMBDs or TOF ratios at extuba-
tion and on arrival to postanesthesia care unit (PACU) was
not studied before. The aim of this investigation is to study this
effect on one of the intermediate-acting NMBD.2. Methods
After Local Ethics Committee approval and patients’ informed
consent, forty-six ASA I–III patients aged 16–60 yr were
enrolled. The enrollment period lasted from September 2011
to March 2012 in King Fahd Military Hospital in Dhahran,
KSA. Inclusion criteria included surgeries expected to last
more than 1 h with positioning that permits access to a
forearm and a hand for neuromuscular monitoring. Exclusion
criteria included surgeries that needed moderate to intense
muscle paralysis or sudden movement of the patient would
induce detrimental effects e.g. intracranial, eye and laparo-
scopic surgeries and bronchoscopy. Patients with known
allergy to amide local anesthetics or seizure activity, those with
known or expected difﬁcult airway or body mass index
>35 kg m2, and those with renal, hepatic or muscle disease
(or taking drugs affecting neuromuscular function) were also
excluded.
Patients were randomly allocated to two groups using com-
puter-generated codes. These codes were kept in sequentially
numbered opaque envelopes. In the morning of surgery, a
member of the pharmacy who was not involved in the study
opened the allocation envelopes and then prepared either lido-
caine 2% or normal saline in ‘‘coded’’ 50-ml syringes. Clinical
monitoring included electrocardiography, pulse oximetry, non-
invasive arterial blood pressure, depth of anesthesia by bispec-
tral index monitor (BIS VISTA, Aspect Medical Systems,
Newton, MA USA) and core temperature via an esophageal
probe inserted after endotracheal intubation. Intravenous
induction was achieved by propofol 2–3 mg kg1 and fentanyl
100–150 mcg. Endotracheal intubation was facilitated by IV
rocuronium 0.6 mg kg1 (based on lean body weight). Immedi-
ately after endotracheal intubation, patients were randomly as-
signed to receive either lidocaine (group L) or placebo saline
(control group C). The syringe contained either lidocaine 2%
to be given to patients in group L as a 1.5 mg kg1 bolus then
1.5 mg kg1 h1 infusion or normal saline to be given to pa-
tients in group C in equal volumes. Infusion was kept running
until endotracheal extubation. The primary anesthesiologist
was blinded to the patient’s group assignment. Anesthesia
was maintained with sevoﬂurane and 40% oxygen in medical
air to maintain BIS from 40 to 60. Lungs were mechanically
ventilated to normocarbia as monitored by capnography. Corebody temperature was kept in the range of 35.5–37 C and the
arm with neuromuscular monitoring >33 C by covering the
patients with forced-air mattress (Bair Hugger, Eden Prairie,
MN). Intraoperative analgesia was accomplished with inter-
mittent doses of fentanyl 50–100 if blood pressure and heart
rate showed sustained elevations (>20% of baseline) for more
than 2 min.
Neuromuscular blockade was monitored at the adductor
pollicis by using acceleromyography (TOF Watch SX, Orga-
non, Inc., Dublin, Ireland). The acceleration transducer was
taped to the distal interphalangeal joint of thumb with the
study arm being immobilized with a splint. The 2 stimulating
electrodes were put on the volar medial side of the forearm
over the ulnar nerve just proximal to the wrist crease after
cleaning the skin with an alcohol swab. Uncalibrated TOF
stimulation (four pulses of 0.2-ms duration at a frequency of
2 Hz) was used. The screen area of the acceleromyography
was covered with a sheet of paper to conceal the TOF ratio.
Rocuronium was not given based on train-of-four (TOF)
count but on one of these clinical signs: 1- any spontaneous
movement of the patient 2-dipping in capnography indicating
trials of breathing 3- more than 20% increase in peak inspira-
tory preassure after excluding bronchospasm and mechanical
obstruction of the endotracheal tube or breathing circuits 4-
sustained increase of blood pressure and heart rate after giving
one fentanyl bolus.
The top-up dose of rocuronium given was 5–10 mg. No
muscle relaxant was given if the expected time of end of sur-
gery was 20–30 min. During this period, boluses of i.v. propo-
fol 20–40 mg were given if needed. Total cumulative dose of
rocuronium and number of top-up doses were recorded.
On conclusion of surgery and a few minutes, sevoﬂurane
was discontinued and all patients were given neostigmine
0.05 mg kg1 mixed with glycopyrrolate 10 mcg kg1 if TOF
count was P2. Extubation criteria included TOF count of 4
with objective tactile evaluation of absence of fade, obeying
simple commands (e.g. eye opening to orders), strong hand
grip, adequate regular breathing and adequate areterial oxy-
genation (SpO2 > 95%). At that time and immediately before
extubation, the sheet of paper was removed from the screen of
TOF Watch SX and TOF ratio was measured and recorded.
Two consecutive TOF ratios (separated by 15 s) were obtained,
and the average of the two values was recorded. If measure-
ments differed by more than 10%, additional TOF ratios were
obtained (to four TOF values), and the closest two ratios were
averaged. Any event of post-extubation laryngospasm was
recorded.
Patients were transferred to postanesthesia care unit
(PACU) with oxygen mask during transfer (4–6 L min1).
Peripheral oxygen saturation (SpO2) was continually measured
in the PACU. An anesthesiologist who was blinded to patients’
allocation recorded TOF ratio on arrival (the same way done
before extubation). Peripheral oxygen saturation (SpO2) on
arrival to PACU was recorded. Any adverse respiratory events
(deﬁned as SpO2 < 95% or airway obstruction requiring inter-
vention i.e. oropharyngeal airway, neck extension, chin lift or
jaw thrust) occurring in the PACU was recorded. Number of
patients showing mild hypoxemia (SpO2 94–90%) or critical
hypoxemia (SpO2 < 90%) were also recorded.
Primary outcome of the study was the TOF ratio at time of
tracheal extubation. Murphy et al. [13] found that mean TOF
ratio immediately before extubation was 0.67(±0.2).
Table 1 Patients characteristics. Data are mean (±SD),
median (range), or number. No statistically signiﬁcant differ-
ences between the 2 study groups. Group C: Control, group L:
Lidocaine.
Group C (n= 23) Group L (n= 23)
Age (yr) 42.6(11.8) 44.1(12.9)
Sex (M/F) 13/10 11/12
Weight (kg) 79.5(16.9) 81.7(19.1)
Height (cm) 167(15.5) 170.5(13)
ASA (I/II/III) 5/11/7 6/9/8
Surgical procedure
General 5 6
Ear, nose and throat 5 4
Plastic 3 2
Orthopedic 4 3
Spine 2 3
Urological 4 5
Surgery time (min) 114(67–211) 109(70–215)
Anesthesia time(min) 144(79–240) 148(80–249)
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Figure 1 End-tidal sevoﬂurane concentration intraoperatively.
Sevoﬂurane concentration in the control group (group C) is
signiﬁcantly higher than in lidocaine group (group L) [analysis of
variance, P< 0.01]. Data are mean (±SD). Time points are 15-
min intervals.
Effect of systemic lidocaine infusion on train-of-four ratios during recovery from general anesthesia 283Assuming that difference of 0.2 in TOF ratio between the
groups would be clinically signiﬁcant, the sample size was cal-
culated to be 21 in each group at alpha error of 0.05 and beta
error of 0.1. Twenty-three patients were allocated per group to
accommodate for drop-outs.Table 2 Intraoperative variables. Data are mean (±SD) or media
group L: Lidocaine. TOF: train of four.
Group C (n=
Fentanyl dose(mcg) 200(100–400)
Rocuronium dose (mg) 55.2(7.9)
Rocuronium top-ups 2(0–6)
Temperature at end of surgery (C) 36.2(0.3)
TOF count at reversal 3(2–4)
Reversal to extubation (min) 11(5.8)
Extubation to transfer to PACU (min) 17.5(4.2)
* Signiﬁcant P value (<0.05).Secondary outcomes included cumulative doses of rocuro-
nium, number of top-up doses, end-tidal sevoﬂurane concen-
trations, TOF count at time of reversal, time from reversal
to extubation, intraoperative doses of fentanyl, incidence of
postextubation laryngospasm, TOF ratio on arrival to PACU
and time the patients were ready to discharge from PACU
based on Aldrete score [14].
Statistical analyses were performed using the SPSS for Win-
dows, version 15 (SPSS Inc., Chicago, IL). Data were ﬁrst
tested for normality by Klomogorov-Smirnov test. Normally
distributed continuous data were analyzed by using student
t-test. Non-normally distributed continuous and ordinal data
were analyzed using Mann–Whitney U test. End-tidal sevoﬂu-
rane concentrations were analyzed by analysis of variance
(ANOVA) test. Categorical data was analyzed by chi square
or Fisher’s exact test as appropriate. The results are presented
as mean ± SD, median (range), or number of patients
(percentages) as appropriate. A P value < 0.05 was considered
statistically signiﬁcant.
3. Results
Seventy-one patients were found eligible for the study. Sixteen
patients met the exclusion criteria and 9 patients refused par-
ticipation. Forty-six patients were randomized to 2 groups:
group C (n= 23) and group L (n= 23). No patient was ex-
cluded from the study.
There were no signiﬁcant differences between the two
groups as regards to age, gender, weight, height, ASA classiﬁ-
cation, and surgical procedures (Table 1). As depicted in
Fig. 1, end-tidal sevoﬂurane concentrations were signiﬁcantly
lower in group L than in group P (P< 0.01).
As shown in Table 2, there were no signiﬁcant differences
between the 2 study groups regarding intraoperative fentanyl
doses or core temperature at the end of surgery. The dose of
rocuronium and the number of its top-up doses were signiﬁ-
cantly less in group L than in group C. The time from neostig-
mine reversal to extubation was signiﬁcantly longer in group C
than group L.
Train-of four ratios were signiﬁcantly higher in group L
than in group C either before extubation or on arrival to
PACU (Table 3). Number of patients with TOF ratios less
than 0.7 or 0.9 was always more in group C than group L
either at extubation or on arrival to PACU yet not statistically
signiﬁcant with TOF < 0.7 on arrival to PACU (Table 3).
Tow patients in group C had post-extubation laryngospasm
while no patients in group L had (P= 0.24). However then (range). PACU: postanesthesia care unit. Group C: Control,
23) Group L (n= 23) P value
200(100–400) 0.9
47.4(6.5) 0.001*
1(0–4) 0.002*
36(0.4) 0.24
4(2–4) 0.11
7.2 (3.6) 0.01*
15.1(4.8) 0.086
Table 3 Train-of-four (TOF) ratios at extubation and on arrival to postanesthesia care unit (PACU). Data are mean (±SD) or
number (percentage). Group C: Control, group L: Lidocaine.
Group C (n= 23) Group L (n= 23) P value
TOF at extubation 0.76(0.07) 0.87(0.09) <0.001*
TOF on arrival to PACU 0.89(0.18) 1.08(0.16) 0.001*
TOF< 0.7 at extubation 8(35) 1(4) 0.011*
TOF< 0.9 at extubation 18(78) 9(39) 0.008*
TOF< 0.7 on arrival to PACU 3(13) 0(0) 0.12
TOF< 0.9 on arrival to PACU 8(35) 2(8) 0.035*
* Signiﬁcant P value (<0.05).
Table 4 Postanesthesia care unit variables. Data are number (proportions). Group C: Control, group L: Lidocaine.
Group C (n= 23) Group L (n= 23) P value
Critical hypoxia 1(4) 0(0) 0.5
Mild hypoxia 5(22) 1(4) 0.09
Need for airway intervention 2(9) 0(0) 0.24
284 A.M. Omarlaryngospasm was partial and treated with applying continu-
ous positive airway pressure.
Table 4 shows that PACU hypoxic events were more com-
mon in group C than in group L albeit not reaching a statisti-
cal signiﬁcance. Two patients in group C needed
oropharyngeal airway insertion to relieve airway obstruction.
Patients in group L needed shorter time (min) to be ready
for discharge from PACU than control group [49.9(16.3) vs.
56.3(13.3), P= 0.15].
4. Discussion
The current study shows that intraoperative use of i.v. lido-
caine infusion in generally anesthetized patients can result in
higher TOF ratios at time of extubation and on arrival to
PACU when rocuronium was given based on clinical signs.
Pederson et al. [7] found that intraoperative qualitative
monitoring of neuromuscular block did not affect the intraop-
erative dose of neuromuscular blocking drug (NMBD) nor did
it increase the TOF ratios measured in PACU when compared
to patients who have received NMBD based on clinical
criteria.
However, the authors did not mention exactly what were
the clinical criteria they relied on to titrate the NMBD (pancu-
ronium and vecuronium). On the contrary, four clinical signs
were predeﬁned to guide the anesthesiologist to titrate rocuro-
nium in the current trial. It was prudent to predeﬁne these clin-
ical signs to decrease the inter-individual variations of NMBD
titration among the 9 attending anesthesiologists who supplied
anesthesia to patients in this study. Because the operations in
which patients’ movement or straining could result in catastro-
phes were excluded, use of NMBD in the current investigation
can be described as ‘‘conservative’’. This conservative ap-
proach may be beneﬁcial in decreasing the incidence of postop-
erative residual recurarization (PORC) which is still high even
with use of intermediate-acting NMBDs [1–6]. When compar-
ing the mean doses of rocuronium (SD) in all study patients
[51.3(7.1)mg] to one recent study by Murphy et al. [15], it
was found that it was nearly 25% less in spite of slight differ-
ences in anesthesia durations between the 2 studies. This maybe attributed to the different methods guiding the titration of
rocuronium in the 2 studies. Murphy et al. [15] used either con-
ventional peripheral nerve stimulator or acceleromyography to
guide repeat doses of rocuronium in comparison to the clinical
criteria used in the current study. It is clear that reliance on
clinical criteria to titrate the NMBDs is not possible in proce-
dures that need deeper levels of muscle relaxation and this can
explain the lower doses of rocuronium used because patients
undergoing theses procedures were excluded from the study.
Train-of-four ratios were always higher either at extubation
time or on arrival to PACU in lidocaine group. Considering
TOF ratio less than 0.7 is a critical value at which dangerous
respiratory events can occur [16], 13% of patients in control
group had recordings less than this value in comparison to
zero percent in lidocaine group. However, this difference does
not reach a statistical signiﬁcance may be because the study
was not powered enough to detect that difference. Neverthe-
less, 35% of patients in control group showed TOF ratios
<0.9 on arrival to PACU in comparison to 8% in lidocaine
group (P= 0.035). When comparing TOF ratios on arrival
to PACU in this study with their counterparts in a recent study
by Murphy et al. [17], it was found that 13% in all study pa-
tients had TOF ratios <0.7 compared to 23% in their study
and 43% had TOF ratios <0.9 in all study patients compared
to 64% in their study. Putting in mind that times of reversal to
TOF ratio measurement were relatively comparable in both
studies, this difference can be attributed to the conservative
clinical guidance of rocuronium titration in the current study
in relation to the use of qualitative and quantitative methods
of neuromuscular monitoring in their study. In spite of using
a quantitative method (acceleromyography) by Murphy et al.
[17] in one group, 14.5% of this group arrived to PACU with
TOF <0.9 compared to 8% of lidocaine group in the current
study.
Cumulative dose of rocuronium used intraoperatively was
found to be 15% less in lidocaine group than in control group.
It seems that this difference was probably responsible for
shorter time of reversal to extubation and the higher TOF ra-
tios in lidocaine group compared to placebo. This difference
could not be explained on pharmacokinetic basis because
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of lidocaine has no impact on the time course of the neuromus-
cular blockade induced by a standard intubation dose of rocu-
ronium [18]. They gave lidocaine infusion (2 mg kg1 h1) to
one group and saline to the other group and used rocuronium
to facilitate endotracheal intubation. They found no differ-
ences between the groups as regards to onset time (to 95%
depression of ﬁrst twitch), total recovery time (TOF ratio
0.9), clinical duration (until ﬁrst twitch has recovered to
25%), recovery index (time between 25% and 75% recovery
of the ﬁrst twitch) and recovery time (between 25% recovery
of the ﬁrst twitch and TOF ratio 0.9).
The probable explanation of decreased needs of rocuroni-
um in lidocaine group is the ability of lidocaine to blunt the
cough airway’s reﬂexes to endotracheal tube. Steinhaus JE
and Gaskin L found that lidocaine prevented coughing in 8
from 10 anesthetized patients stimulated by manual displace-
ment of the endotracheal tube [19]. Poulton TJ and James
FM III found that lidocaine could signiﬁcantly decrease the
cough responses of awake unmedicated persons [20]. Blunting
of airway reﬂexes was speculated to be the mechanism of this
favorable effect. Based on these early studies, investigators
have shown that lidocaine could be useful in preventing cough
related to endotracheal intubation [21] and extubation [22].
The dose of lidocaine bolus and infusion used in the study
was based on many previous studies that showed that range of
1.5–2 mg kg1 h1 did not result in plasma concentration high-
er than 4 mcg ml1 [11,23,24] which is still below the toxic lev-
els (5 mcg ml) [25].
Decreased end-tidal concentrations of sevoﬂurane required
to keep BIS between 40 and 60 in lidocaine group may be ex-
plained by its inhibitory effects on central nervous system. Sys-
temic local anesthetics reduce minimum alveolar concentration
(MAC) of volatile anesthetics in animals by 20–40% [26,27].
However the study was not powered or designed to detect
the effect of lidocaine on MAC.
The results of this study may be encouraging to use lido-
caine infusion in general anesthesia to decrease NMBD doses
in places lacking quantitative neuromuscular monitors. How-
ever one limitation of this study is inappropriateness of this
conservative use of NMBD in surgeries that necessitate deep
muscle relaxation.
In conclusion, intravenous lidocaine infusion can increase
TOF ratios at time of extubation and on arrival to PACU
compared to placebo when rocuronium was titrated based so-
lely on clinical criteria.
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